Ashley Hall
2020
In 2020, Ashley Hall earned a total compensation of $2.3M as Former Chief Development Officer at Esperion Therapeutics.
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Non-Equity Incentive Plan | $145,000 |
| Option Awards | $1,073,411 |
| Salary | $435,000 |
| Stock Awards | $337,370 |
| Other | $9,750 |
| Total | $2,300,531 |
Hall received $1.1M in option awards, accounting for 47% of the total pay in 2020.
Hall also received $300K in bonus, $145K in non-equity incentive plan, $435K in salary, $337.4K in stock awards and $9.8K in other compensation.
Rankings
In 2020, Ashley Hall's compensation ranked 4,915th out of 13,090 executives tracked by ExecPay. In other words, Hall earned more than 62.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,915 out of 13,090 | 63rd |
Division Manufacturing | 1,994 out of 5,624 | 65th |
Major group Chemicals And Allied Products | 791 out of 2,257 | 65th |
Industry group Drugs | 682 out of 1,957 | 65th |
Industry Pharmaceutical Preparations | 513 out of 1,462 | 65th |
Source: SEC filing on April 14, 2022.
Hall's colleagues
We found three more compensation records of executives who worked with Ashley Hall at Esperion Therapeutics in 2020.